Crinecerfont
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Glucocorticoid Reduction After Starting Crinecerfont in Adult Patients with Classic CAH: Practical Perspectives.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 22, 2025
Crinecerfont: CRF1R Antagonist Approved for Treatment of Congenital Adrenal Hyperplasia.
Journal: The Annals of pharmacotherapy
Published: December 01, 2025
Correction: CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance.
Journal: Frontiers in endocrinology
Published: September 29, 2025
What is the need for adrenalectomy in patients with congenital adrenal hyperplasia in the era of CRF1/ACTH inhibitors?
Journal: Frontiers in endocrinology
Published: August 26, 2025
CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance.
Journal: Frontiers in endocrinology
Published: June 14, 2025
Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 20, 2025
Crinecerfont.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: March 04, 2025
Efficacy and safety of crinecerfont for the treatment of congenital adrenal hyperplasia.
Journal: European journal of internal medicine
Published: December 24, 2024
Crinecerfont in Adult Congenital Adrenal Hyperplasia. Reply.
Journal: The New England journal of medicine
Published: October 23, 2024
Last Updated: 04/28/2026